These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2900182

  • 1. Functional hyperthermia due to central dopaminergic impairment.
    Di Rosa AE, Morgante L, Coraci MA, Crisafulli A, Cacciola G, Di Stefano G, Meduri M, Di Perri R.
    Funct Neurol; 1988; 3(2):211-5. PubMed ID: 2900182
    [Abstract] [Full Text] [Related]

  • 2. Neuroleptic malignant syndrome.
    McHugh TP.
    J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
    [Abstract] [Full Text] [Related]

  • 3. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC, Chew EL, Ong YY.
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [Abstract] [Full Text] [Related]

  • 4. Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
    Figà-Talamanca L, Gualandi C, Di Meo L, Di Battista G, Neri G, Lo Russo F.
    Neurology; 1985 Feb; 35(2):258-61. PubMed ID: 3969217
    [Abstract] [Full Text] [Related]

  • 5. Neuroleptic malignant syndrome without neuroleptics.
    Parsa MA, Rohr T, Ramirez LF, Meltzer HY.
    J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
    [No Abstract] [Full Text] [Related]

  • 6. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS, Lindsay S, Strawn JR, Kaneria RM, Patel NC, Keck PE.
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [Abstract] [Full Text] [Related]

  • 7. Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
    Rainer C, Scheinost NA, Lefeber EJ.
    Postgrad Med; 1991 Apr; 89(5):175-8, 180. PubMed ID: 2008397
    [Abstract] [Full Text] [Related]

  • 8. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome.
    Granner MA, Wooten GF.
    Semin Neurol; 1991 Sep; 11(3):228-35. PubMed ID: 1947485
    [Abstract] [Full Text] [Related]

  • 9. Neuroleptic malignant syndrome-like, or--dopaminergic malignant syndrome--due to levodopa therapy withdrawal. Clinical features in 11 patients.
    Serrano-Dueñas M.
    Parkinsonism Relat Disord; 2003 Jan; 9(3):175-8. PubMed ID: 12573874
    [Abstract] [Full Text] [Related]

  • 10. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
    Ward C.
    J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
    [Abstract] [Full Text] [Related]

  • 11. A 73-year-old woman with confusion, rigidity, and fever.
    Altus P, Weissman MS, Hencey MA.
    Hosp Pract (Off Ed); 1991 Jun 15; 26(6):97-8, 100. PubMed ID: 2040682
    [No Abstract] [Full Text] [Related]

  • 12. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.
    Harsch HH.
    J Clin Psychiatry; 1987 Aug 15; 48(8):328-33. PubMed ID: 2886491
    [Abstract] [Full Text] [Related]

  • 13. [Cholestasis caused by Nakom].
    Bukhanov VP.
    Klin Med (Mosk); 1988 May 15; 66(5):126-8. PubMed ID: 3419093
    [No Abstract] [Full Text] [Related]

  • 14. Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Zesiewicz TA, Borra S, Hauser RA.
    Mov Disord; 2002 Nov 15; 17(6):1365-7. PubMed ID: 12465085
    [Abstract] [Full Text] [Related]

  • 15. Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
    Freedman MD.
    Md Med J; 1997 Aug 15; 46(7):357-9. PubMed ID: 9260471
    [Abstract] [Full Text] [Related]

  • 16. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A, Bodini P, Dizioli P, Chiodelli G, Guarneri M, Boldori L.
    Minerva Med; 1996 Aug 15; 87(1-2):45-51. PubMed ID: 8610025
    [Abstract] [Full Text] [Related]

  • 17. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
    Friedman JH, Feinberg SS, Feldman RG.
    JAMA; 1985 Nov 15; 254(19):2792-5. PubMed ID: 4057489
    [Abstract] [Full Text] [Related]

  • 18. Drug-induced movement disorders.
    Gershanik OS.
    Curr Opin Neurol Neurosurg; 1993 Jun 15; 6(3):369-76. PubMed ID: 8099509
    [Abstract] [Full Text] [Related]

  • 19. Endovascular cooling in a patient with neuroleptic malignant syndrome.
    Diedler J, Mellado P, Veltkamp R.
    J Neurol Sci; 2008 Jan 15; 264(1-2):163-5. PubMed ID: 17706678
    [Abstract] [Full Text] [Related]

  • 20. Neuroleptic malignant syndrome: need for early diagnosis and therapy.
    Khan HM, Syed NA, Sheerani M, Khcalani B, Kamal A, Wasay M.
    J Ayub Med Coll Abbottabad; 2006 Jan 15; 18(1):17-21. PubMed ID: 16773963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.